For those aiming to lose weight and meet clinical BMI thresholds, Wegovy is an excellent choice
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
Our Comprehensive Telehealth Weight Loss Program Includes: One-on-One Virtual Consultation: Connect with our expert healthcare providers who will assess your health history, goals, and lifestyle to develop a personalized plan
For weight loss the recommended starting dose of Ozempic is 0.25 mg
Another potential plus: price